These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 30300440)
21. Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints. Bhavnani SM; Trang M; Griffith DC; Lomovskaya O; Hammel JP; Loutit JS; Cammarata SK; Dudley MN; Ambrose PG; Rubino CM Antimicrob Agents Chemother; 2022 Dec; 66(12):e0213021. PubMed ID: 36374023 [TBL] [Abstract][Full Text] [Related]
22. Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae. Cojutti P; Sartor A; Righi E; Scarparo C; Bassetti M; Pea F Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760900 [TBL] [Abstract][Full Text] [Related]
23. Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? Pea F; Della Siega P; Cojutti P; Sartor A; Crapis M; Scarparo C; Bassetti M Int J Antimicrob Agents; 2017 Feb; 49(2):255-258. PubMed ID: 28012683 [TBL] [Abstract][Full Text] [Related]
24. Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox? Del Bono V; Giacobbe DR; Marchese A; Parisini A; Fucile C; Coppo E; Marini V; Arena A; Molin A; Martelli A; Gratarola A; Viscoli C; Pelosi P; Mattioli F Virulence; 2017 Jan; 8(1):66-73. PubMed ID: 27430122 [TBL] [Abstract][Full Text] [Related]
25. The antibiotic arms race: current and emerging therapy for Plazak ME; Tamma PD; Heil EL Expert Opin Pharmacother; 2018 Dec; 19(18):2019-2031. PubMed ID: 30346216 [No Abstract] [Full Text] [Related]
26. Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae. Castanheira M; Rhomberg PR; Flamm RK; Jones RN Antimicrob Agents Chemother; 2016 Sep; 60(9):5454-8. PubMed ID: 27381386 [TBL] [Abstract][Full Text] [Related]
27. Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in an Sabet M; Tarazi Z; Rubio-Aparicio D; Nolan TG; Parkinson J; Lomovskaya O; Dudley MN; Griffith DC Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133570 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of tigecycline alone or in combination for experimental infections by KPC carbapenemase-producing Klebsiella pneumoniae. Fergadaki S; Renieris G; Machairas N; Sabracos L; Droggiti DI; Misiakos E; Giamarellos-Bourboulis EJ Int J Antimicrob Agents; 2021 Sep; 58(3):106384. PubMed ID: 34161789 [TBL] [Abstract][Full Text] [Related]
29. In vitro activity of meropenem combined with vaborbactam against KPC-producing Enterobacteriaceae in China. Zhou M; Yang Q; Lomovskaya O; Sun D; Kudinha T; Xu Z; Zhang G; Chen X; Xu Y J Antimicrob Chemother; 2018 Oct; 73(10):2789-2796. PubMed ID: 29982437 [TBL] [Abstract][Full Text] [Related]
30. Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections. Dhillon S Drugs; 2018 Aug; 78(12):1259-1270. PubMed ID: 30128699 [TBL] [Abstract][Full Text] [Related]
31. Meropenem/Vaborbactam, the First Carbapenem/β-Lactamase Inhibitor Combination. Cho JC; Zmarlicka MT; Shaeer KM; Pardo J Ann Pharmacother; 2018 Aug; 52(8):769-779. PubMed ID: 29514462 [TBL] [Abstract][Full Text] [Related]
32. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725 [TBL] [Abstract][Full Text] [Related]
33. A Post-Neurosurgical Infection due to KPC-Producing Klebsiella pneumoniae Treated with Meropenem-Vaborbactam: A Case Report. Choi S; Fedorenko M; Lin-Torre J; Mistry N; Smoke S Int J Infect Dis; 2022 Sep; 122():1041-1043. PubMed ID: 35932967 [TBL] [Abstract][Full Text] [Related]
34. Looking beyond ceftazidime-avibactam resistance in KPC-producing Boattini M; Bianco G; Iannaccone M; Bondi A; Cavallo R; Costa C J Chemother; 2021 Dec; 33(8):598-600. PubMed ID: 33843501 [No Abstract] [Full Text] [Related]